BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 19444602)

  • 1. Reporting of race and ethnicity in breast cancer research: room for improvement.
    Mitchell KW; Carey LA; Peppercorn J
    Breast Cancer Res Treat; 2009 Dec; 118(3):511-7. PubMed ID: 19444602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reporting and representation of race/ethnicity in published randomized trials.
    Berger JS; Melloni C; Wang TY; Dolor RJ; Frazier CG; Samad Z; Peterson ED; Mark DB; Newby LK
    Am Heart J; 2009 Nov; 158(5):742-7. PubMed ID: 19853691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in reporting of race/ethnicity, socioeconomic status, gender, and age over 10 years.
    Brahan D; Bauchner H
    Pediatrics; 2005 Feb; 115(2):e163-6. PubMed ID: 15687424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A report on accrual rates for elderly and minority-ethnicity cancer patients to clinical trials of the American College of Surgeons Oncology Group.
    Newman LA; Hurd T; Leitch M; Kuerer HM; Diehl K; Lucci A; Giuliano A; Hunt KK; Putnam W; Wells SA
    J Am Coll Surg; 2004 Oct; 199(4):644-51. PubMed ID: 15454152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in breast cancer hormone receptor status and histology by race and ethnicity among women 50 years of age and older.
    Li CI; Malone KE; Daling JR
    Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):601-7. PubMed ID: 12101106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in area-socioeconomic and race-ethnic disparities in breast cancer incidence, stage at diagnosis, screening, mortality, and survival among women ages 50 years and over (1987-2005).
    Harper S; Lynch J; Meersman SC; Breen N; Davis WW; Reichman MC
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):121-31. PubMed ID: 19124489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between pharmaceutical involvement and outcomes in breast cancer clinical trials.
    Peppercorn J; Blood E; Winer E; Partridge A
    Cancer; 2007 Apr; 109(7):1239-46. PubMed ID: 17326054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The validity of race and Hispanic origin reporting on death certificates in the United States.
    Arias E; Schauman WS; Eschbach K; Sorlie PD; Backlund E
    Vital Health Stat 2; 2008 Oct; (148):1-23. PubMed ID: 19024798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Race, ethnicity, and use of thiazolidinediones among US adults with diabetes.
    Aquilante CL; Zhang W; McCollum M
    Curr Med Res Opin; 2007 Mar; 23(3):489-94. PubMed ID: 17355730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of Hispanic race/ethnicity and poverty in breast cancer survival.
    Delgado DJ; Lin WY; Coffey M
    P R Health Sci J; 1995 Jun; 14(2):103-16. PubMed ID: 7617830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disparities in mammography use among US women aged 40-64 years, by race, ethnicity, income, and health insurance status, 1993 and 2005.
    Sabatino SA; Coates RJ; Uhler RJ; Breen N; Tangka F; Shaw KM
    Med Care; 2008 Jul; 46(7):692-700. PubMed ID: 18580388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of the physician on the accrual to randomized clinical trials in patients with primary operable breast cancer.
    Kaas R; Hart AA; Rutgers EJ
    Breast; 2005 Aug; 14(4):310-6. PubMed ID: 16085238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are all aromatase inhibitors the same? A review of controlled clinical trials in breast cancer.
    Berry J
    Clin Ther; 2005 Nov; 27(11):1671-84. PubMed ID: 16368441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of the National Cancer Data Base to develop clinical trials accrual targets that are appropriate for minority ethnicity patients: a report from the American College of Surgeons Oncology Group (ACOSOG) Special Population Committee.
    Newman LA; Lee CT; Parekh LP; Stewart AK; Thomas CR; Beltran RA; Lucci A; Green B; Ota D; Nelson H;
    Cancer; 2006 Jan; 106(1):188-95. PubMed ID: 16333856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Categorizing race and ethnicity in the HMO Cancer Research Network.
    Ford ME; Hill DD; Nerenz D; Hornbrook M; Zapka J; Meenan R; Greene S; Johnson CC
    Ethn Dis; 2002; 12(1):135-40. PubMed ID: 11913601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variation in Accrual and Race/Ethnicity Reporting in Urological and Nonurological Related Cancer Trials.
    Paul K; Sathianathen N; Dahm P; Le C; Konety BR
    J Urol; 2019 Aug; 202(2):385-391. PubMed ID: 31074679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Race/ethnicity in medical charts and administrative databases of patients served by community health centers.
    Maizlish N; Herrera L
    Ethn Dis; 2006; 16(2):483-7. PubMed ID: 17682252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Race" and "ethnicity" in biomedical research: how do scientists construct and explain differences in health?
    Lee C
    Soc Sci Med; 2009 Mar; 68(6):1183-90. PubMed ID: 19185964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The identification and treatment of isolated tumor cells reflect disparities in the delivery of breast cancer care.
    Tan JT; Bagnell M; Morgan JW; Wong JH; Roy-Chowdhury S; Lum SS
    Am J Surg; 2009 Oct; 198(4):508-10. PubMed ID: 19800457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Misclassification of race/ethnicity in a population-based cancer registry (United States).
    Gomez SL; Glaser SL
    Cancer Causes Control; 2006 Aug; 17(6):771-81. PubMed ID: 16783605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.